Evan Lipson

Associate Professor

20052019

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Evan Lipson is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 8 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Open Access
  • Cardiovascular toxicities associated with immune checkpoint inhibitors

    Hu, J. R., Florido, R., Lipson, E., Naidoo, J., Ardehali, R., Tocchetti, C. G., Lyon, A. R., Padera, R. F., Johnson, D. B. & Moslehi, J., Apr 15 2019, In : Cardiovascular research. 115, 5, p. 854-868 15 p.

    Research output: Contribution to journalArticle

    Open Access
  • Durable tumor regression and overall survival in patients with advanced Merkel cell carcinoma receiving pembrolizumab as first-line therapy

    Nghiem, P., Bhatia, S., Lipson, E., Sharfman, W., Kudchadkar, R. R., Brohl, A. S., Friedlander, P. A., Daud, A., Kluger, H. M., Reddy, S. A., Boulmay, B. C., Riker, A. I., Burgess, M. A., Hanks, B. A., Olencki, T., Margolin, K., Lundgren, L. M., Soni, A., Ramchurren, N., Church, C. & 11 others, Park, S. Y., Shinohara, M. M., Salim, B., Taube, J. M., Bird, S. R., Ibrahim, N., Fling, S. P., Moreno, B. H., Sharon, E., Cheever, M. A. & Topalian, S., Mar 20 2019, In : Journal of Clinical Oncology. 37, 9, p. 693-702 10 p.

    Research output: Contribution to journalArticle